D-0393-2021 Class II Ongoing

Recalled by Noven Pharmaceuticals Inc — Miami, FL

FDA drug recall D-0393-2021 was initiated by Noven Pharmaceuticals Inc on May 20, 2021 and is designated Class II. Reason for recall: Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits. The recall status is ongoing. Affected quantity: 9,587 boxes.

Recall details

Product Type
Drugs
Report Date
Jun 2, 2021
Initiation Date
May 20, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,587 boxes

Product description

Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches (NDC 68968-5552-1) per box (NDC 68968-5552-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.

Reason for recall

Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

Distribution pattern

Nationwide in the USA

Code information

Lot: 88528 Exp. 09/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0393-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0393-2021. Report a data issue: hello@regdatalab.com.